Faculty of Medicine

Permanent URI for this communityhttps://repository.ukim.mk/handle/20.500.12188/14

Browse

Settings

Author: search.filters.author.Elma KandicHas files: Yes

Search Results

Now showing 1 - 3 of 3
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    Acute Arterial Thrombosis in Anticoagulated Patient for Acute Pulmonary Thromboembolism
    (Nizameddin KOCA, 2023-04-29)
    ;
    ;
    Elena Grueva
    ;
    Elma Kandic
    ;
    Oliver Bushljetikj
    Acute limb ischemia is a rare condition in patients with venous thromboembolism (VTE), who already receive anticoagulation treatment. Inflammation is a risk factor for thrombus formation. Patients with active ulcerative colitis, especially at time of exacerbation, are more prone to thromboembolism, both venous and arterial. Risk for thrombosis is 18% higher risk, with also higher risk of bleeding. Up to date, there is no contraindication to any anticoagulant drug in patients with ulcerative colitis. We represent a case of a 73 year - old woman with ulcerative colitis (UC) exacerbation, hospitalized initially for pulmonary thromboembolism, that developed acute arterial thrombosis when switched on novel oral anticoagulant (NOAC).
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    Acute Myocarditis after Pfizer-BioNTech COVID-19 m-RNA Vaccination
    (Scientific Foundation SPIROSKI, 2022-11-30)
    Elena Grueva-Nastevska
    ;
    ;
    Planinka Zafirovska
    ;
    Elma Kandic
    ;
    BACKGROUND: Prosthetic mechanical valve endocarditis (PVE) can be manifested as early PVE (acquired perioperatively) and late PVE (resulting from infections unrelated to the valve operation). Causes of both are similar but are late PVE are more prone to less virulent microbes. PVE resulting with paravalvular abscess is confirmed through echocardiography (transthoracic or transesophageal), it results with a high mortality rate especially if it is not early recognized. CASE PRESENTATION: We are presenting a patient with heart failure symptoms caused by PVE after Pfizer-BioNTech coronavirus disease-2019 (COVID-19) m-RNA vaccination. CONCLUSION: The exact mechanism of myocarditis in young men who received the second dose of mRNA COVID-19 vaccine is not yet known. However, this is a rare complication and most people generally recover quickly requiring only supportive treatment. In contrast, the risk of developing myocarditis from the viral infection is much higher.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Item type:Publication,
    Fulminant myocarditis in COVID-19 - Case report
    (Macedonian Pharmaceutical Association = Македонско фармацевтско друштво, 2021-01)
    Elena Grueva Nastevska
    ;
    ;
    Elma Kandic
    ;
    Vladislav Gruev
    ;